(Q63814053)
Statements
A Double-Blind, Randomized,Placebo-Controlled, Two-Phase Study (a Single Ascending Dose Phase Followed by a Proof of Concept Phase) to Assess the Safety, Efficacy and Pharmacokinetics of FX005 for the Treatment of Pain in Osteoarthritis of the Knee (English)
0 references
December 2010
0 references
January 2012
0 references
140
0 references
40 year
0 references